Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Soudeh Kaveh"'
Autor:
Mohammad Zamani, Hossein Poustchi, Zahra Mohammadi, Sahar Dalvand, Maryam Sharafkhah, Seyed Abbas Motevalian, Saeid Eslami, Amir Emami, Mohammad Hossein Somi, Jamshid Yazdani-Charati, Nader Saki, Manoochehr Karami, Farid Najafi, Iraj Mohebbi, Nasrollah Veisi, Ahmad Hormati, Farhad Pourfarzi, Reza Ghadimi, Alireza Ansari-Moghaddam, Hamid Sharifi, Gholamreza Roshandel, Fariborz Mansour-Ghanaei, Farahnaz Joukar, Amaneh Shayanrad, Sareh Eghtesad, Ahmadreza Niavarani, Alireza Delavari, Soudeh Kaveh, Akbar Feizesani, Melineh Markarian, Fatemeh Shafighian, Alireza Sadjadi, Maryam Darvishian, Reza Malekzadeh
Publikováno v:
BMC Public Health, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background The first large serosurvey in Iran found a SARS-CoV-2 antibody seroprevalence of 17.1% among the general population in the first wave of the epidemic by April, 2020. The purpose of the current study was to assess the seroprevalenc
Externí odkaz:
https://doaj.org/article/94e4dc12fdf2465092256e5007810318
Autor:
Fatemeh Shafighian, Farhad Pourfarzi, Ahmadreza Niavarani, Majid Saeedi, Sareh Eghtesad, Payam Tabarsi, Ebrahim Shakiba, Alireza Sadjadi, Alireza Ansari-Moghaddam, Shaghayegh Haghjooy Javanmard, Fariborz Mansour-Ghanaei, Amir Reza Radmard, Iraj Mohebbi, Hossein Poustchi, Saeid Eslami, Mohammad Hossein Somi, Maryam Sharafkhah, Amir Emami, Nasrollah Veisi, Manoochehr Karami, Amaneh Shayanrad, Mohammad Amani, Reza Malekzadeh, Soudeh Kaveh, Alireza Delavari, Majid Sorouri, Hossein Keyvani, Zahra Mohammadi, Ali Ali Asgari, Anahita Sadeghi, Hamid Sharifi, Ahmad Hormati, Reza Ghadimi, Melineh Markarian, Ayad Bahadorimonfared, Akbar Feizesani, Amir Anushiravani, Ali Reza Sima, Fatemeh Ghasemi-Kebria, Nader Saki, Maryam Darvishian, Ali H. Mokdad
Publikováno v:
The Lancet Infectious Diseases
Summary Background Rapid increases in cases of COVID-19 were observed in multiple cities in Iran towards the start of the pandemic. However, the true infection rate remains unknown. We aimed to assess the seroprevalence of antibodies against severe a
Autor:
Hossein Poustchi, Alireza Sadjadi, Nasrollah Veisi, Fariborz Mansour-Ghanaei, Ahmad Hormati, Maryam Sharafkhah, Fatemeh Ghasemi-Kebria, Amir Anushiravani, Zahra Mohammadi, Manoochehr Karami, Nader Saki, Majid Saeedi, Payam Tabarsi, Alireza Ansari-Moghaddam, Anahita Sadeghi, Iraj Mohebbi, Hossein Keyvani, Maryam Darvishian, Amir Emami, Alireza Delavari, Sareh Eghtesad, Reza Malekzadeh, Soudeh Kaveh, Reza Ghadimi, Hamid Sharifi, Mohammad Hossein Somi, Akbar Feizesani, Ali Ali Asgari, Fatemeh Shafighian, Ebrahim Shakiba, Ayad Bahadorimonfared, Farhad Pourfarzi, Melineh Markarian, Ali H. Mokdad, Mohammad Amani, Ali Reza Sima, Saeid Eslami, Majid Sorouri, Amaneh Shayanrad, Amir Reza Radmard, Shaghayegh Haghjooy Javanmard
Publikováno v:
SSRN Electronic Journal.
Background: As the COVID-19 pandemic unfolded, rapid case increase was observed in multiple cities in Iran. However, in the absence of seroprevalence surveys, the true infection rate remains unknown. In this population-based study we assessed the ser
Autor:
Behzad Hajarizadeh, Maryam Alavi, Shahin Merat, Hossein Poustchi, Afarin Rahimi-Movaghar, Jason Grebely, Soudeh Kaveh-ei, Reza Malekzadeh, Behrang Shadloo, Gregory J. Dore
Publikováno v:
The International journal on drug policy. 72
Background Globally, HCV testing, linkage to care and treatment is sub-optimal among people who use drugs (PWUD). This study aimed to evaluate the impact of an innovative intervention to enhance HCV testing, linkage to care, and treatment initiation